The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of Southern California
Study ID
NCT05746143
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Lumbar Spine Degeneration
  • Lumbar Spine Spondylosis
  • Pain, Postoperative
  • Spine Fusion

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Zolpidem Tartrate 10 mg — DRUG
    two days preoperatively and five days postoperatively
  • Placebo — DRUG
    two days preoperatively and five days postoperatively

Study Details

The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.

Key Dates

Start date
Feb 1, 2022
Status verified
Apr 2026
Primary completion
Jan 31, 2029
Completion
Dec 31, 2030

Study Design

Enrollment
140 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Zolpidem
  • Placebo Comparator: Placebo

Primary Outcome Measure

Visual analog scale (VAS) [ Time Frame: Postoperative day five ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Keck Medical Center of USCLos AngelesCalifornia90033
Pui Yan, MS
[email protected]
323-442-6984

Find similar trials in Los Angeles, CA

By research site
Keck Medical Center of USC· Los Angeles, CA

Related Studies